Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
Replek AD Skopje
sales of 829.32 million Denar [US$15.06 million]
(143.63 million Norwegian Kroner [US$17.15 million]
of which 48%
was Hexvix/Cysview Own Sales), and
Science In Sport Plc
based in the United Kingdom
(£12.24 million [US$15.88 million]
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Santhera Pharmaceuticals Holding AG were 19.03 million Swiss Francs (US$19.50 million).
increase of 340.5%
versus 2015, when the company's sales were 4.32 million Swiss Francs.
This was the third consecutive year of growth at Santhera Pharmaceuticals Holding AG.